NLRP6 and colitis: The in vivo evidence for NLRP6 inflammasome formation was provided by the demonstration that Nlrp6−/− mice have reduced serum IL-18 levels under steady-state conditions and after dextran sulfate sodium (DSS)-induced colitis compared with that of wild-type (WT) controls (Elinav et al., 2011).